Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Physiologically based pharmacokinetic characteristics

What are called physiologically based pharmacokinetic (PBPK) and pharmacodynamic (PBPD) models are more mechanistically complex and often include more compartments, more parameters, and more detailed expressions of rates and fluxes and contain more mechanistic representation. This type of model is reviewed in more detail in Section 22.5. Here, we merely classify such models and note several characteristics. PBPK models have more parameters, are more mechanistic, can exploit a wider range of data, often represent the whole body, and can be used both to describe and interpolate as well as to predict and extrapolate. Complexity of such models ranges from moderate to high. They typically contain 10 or more compartments, and can range to hundreds. The increase in the number of flux relationships between compartments and the related parameters is often more than proportional to compartment count. [Pg.537]

Oliver, R., Jones, A., and Rowland, M., A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts Short and long time characteristics, Journal of Pharmacokinetics and Biopharmaceutics, Vol. 28, No. 1, 2001, pp. 27-55. [Pg.409]

Physiologically based pharmacokinetic (PBPK) models are a special type of PK model that attempts to provide more definition to the model analysis by incorporating physiological factors into the model design, like tissue volumes, blood flow rates, and species-specific enzyme characteristics that can more accurately differentiate the dose-response relationship for a chemical or drug in one species from that of another species. The power of this approach is to be able to perform laboratory studies, both in vitro and in vivo, in common experimental species... [Pg.791]

Physiologically based pharmacokinetic (PB-PK) models for some JP-8 components have been developed to understand the relationship between vapor concentrations and accumulation in tissue and blood compartments. When appropriately developed and validated, PB-PK models can provide a time course of distribution of a chemical or its metabolites in tissues and show the effect of changingphysiologic characteristics on plasma and tissue concentrations. PB-PK models have been applied to predict toxicokinetic parameters and to scale dose in different species. [Pg.32]


See other pages where Physiologically based pharmacokinetic characteristics is mentioned: [Pg.537]    [Pg.381]    [Pg.771]    [Pg.35]    [Pg.295]    [Pg.672]    [Pg.214]    [Pg.730]    [Pg.234]    [Pg.422]    [Pg.731]    [Pg.315]    [Pg.455]    [Pg.91]    [Pg.494]    [Pg.340]    [Pg.1263]    [Pg.15]    [Pg.1415]    [Pg.398]    [Pg.208]    [Pg.82]    [Pg.193]    [Pg.1194]    [Pg.27]    [Pg.344]    [Pg.1145]    [Pg.121]    [Pg.100]    [Pg.605]    [Pg.203]    [Pg.81]   
See also in sourсe #XX -- [ Pg.558 , Pg.559 , Pg.559 , Pg.560 , Pg.561 , Pg.561 , Pg.562 ]




SEARCH



Bases characteristics

Pharmacokinetic characteristics

Pharmacokinetic physiological

Pharmacokinetics physiological

Physiologically based

Physiologically based pharmacokinetic

© 2024 chempedia.info